This review summarizes recent developments in nanocontainer-based smart functional
coatings done during the last 15 years. These types of coatings were first developed by …

Chitosan, a biocompatible natural polysaccharide is frequently reported carrier material in
targeted drug delivery to treat neurodegenerative disorders. Chitosan and its biodegradable …

Rivastigmine hydrogen tartrate (RHT), one of the potential cholinesterase inhibitors, has
received great attention as a new drug candidate for the treatment of Alzheimer's disease …

Alzheimer's disease (AD) is characterised by extracellular amyloid deposits, neurofibrillary
tangles, synaptic loss, inflammation and extensive oxidative stress. Polyphenols, which …

Brain delivery of drugs faces limitations due to the physiological and physical barriers. One
of the strategies to overcome this problem is the use of nanotechnology in a pharmaceutical …

Chronic inflammatory events appear to play a fundamental role in Alzheimer's disease (AD)-
related neuropathological changes, and to result in neuronal dysfunction and death. The …

One major challenge in the field of nanotherapeutics is to increase the selective delivery of
cargo to targeted cells. Using polylactic-co-glycolic acid (PLGA), we recently highlighted the …

During the last decades, substances from secondary metabolism of a number of plants and
their derivatives have been investigated due to their important biological activities and …

ABSTRACT Introduction: Neurodegenerative diseases (NDs) represent intricate challenges
for efficient uptake and transport of drugs to the brain mainly due to the restrictive blood …

Alzheimer's disease (AD) is a progressive neurodegenerative disease that disrupts cognitive
function and severely affects the quality of life. Existing drugs only improve cognitive function …